Literature DB >> 2851775

Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas.

D Katenkamp1.   

Abstract

Many human soft tissue sarcomas are known to show variable structures in a given tumor and to be able of changing the histological feature during the course of the disease. These facts prompted an experimental study in order to ascertain if by use of long-term cultures of an established rat fibrosarcoma cell line (RFS) in respective inoculation tumors a histological picture different from the original fibrosarcoma could be produced. It was found that inoculation tumors generated by later subcultures partly corresponded to tumors with features of malignant histiocytomas and malignant fibrous histiocytomas. In a further experiment we attempted to initiate metastatic dissemination of a primarily non-metastasizing xenotransplanted RFS sarcoma in nude mice. By repeated diminution operations comparable to inadequate tumor surgery in human metastasis formation in lung parenchyme was attained. Taking into account cellular heterogeneity as basically responsible for the phenomena observed, different causal aspects concerning the experimental results are discussed. We deduce from our findings that the concept of histogenetic classification of soft tissue sarcomas should be replaced by an interpretation according to the actual differentiation. This also applies to malignant fibrous histiocytomas which are at least in part mesenchymal tumors and not descendants of mononuclear phagocytic cells and may originate by a dedifferentiation process of otherwise defined sarcoma types.

Entities:  

Mesh:

Year:  1988        PMID: 2851775     DOI: 10.1016/S0344-0338(88)80055-4

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.

Authors:  Jinhyang Choi; Stephen J Curtis; David M Roy; Andrea Flesken-Nikitin; Alexander Yu Nikitin
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

2.  [Malignant fibrous histiocytoma: pleomorphic sarcoma NOS or pleomorphic fibrosarcoma].

Authors:  P Meister
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

3.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

4.  Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.

Authors:  Stefan Wirths; Elke Malenke; Torsten Kluba; Simone Rieger; Martin R Müller; Sabine Schleicher; Claus Hann von Weyhern; Florian Nagl; Falko Fend; Wichard Vogel; Frank Mayer; Lothar Kanz; Hans-Jörg Bühring; Hans-Georg Kopp
Journal:  Stem Cells Transl Med       Date:  2012-12-19       Impact factor: 6.940

5.  Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-P.

Authors:  G Edel; A Roessner; B Deneke; B Wörmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  [Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases].

Authors:  M Lehnhardt; A Daigeler; H H Homann; J Hauser; S Langer; L Steinsträsser; C Soimaru; A Puls; H U Steinau
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

7.  Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.

Authors:  I Ray-Coquard; M C Montesco; J M Coindre; A P Dei Tos; A Lurkin; D Ranchère-Vince; A Vecchiato; A V Decouvelaere; S Mathoulin-Pélissier; S Albert; P Cousin; D Cellier; L Toffolatti; C R Rossi; J Y Blay
Journal:  Ann Oncol       Date:  2012-02-13       Impact factor: 32.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.